PDB Short entry for 1ITI HEADER CYTOKINE 12-APR-93 1ITI TITLE THE HIGH RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN TITLE 2 INTERLEUKIN-4 DETERMINED BY MULTI-DIMENSIONAL HETERONUCLEAR MAGNETIC TITLE 3 RESONANCE SPECTROSCOPY COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-4; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: POTENTIAL KEYWDS INTERLEUKIN-4, CYTOKINE EXPDTA SOLUTION NMR NUMMDL 31 AUTHOR G.M.CLORE,B.POWERS,D.S.GARRETT,A.M.GRONENBORN REVDAT 5 23-FEB-22 1ITI 1 REMARK SEQADV REVDAT 4 24-FEB-09 1ITI 1 VERSN REVDAT 3 01-APR-03 1ITI 1 JRNL REVDAT 2 15-FEB-01 1ITI 1 TITLE KEYWDS EXPDTA JRNL REVDAT 1 15-JUL-93 1ITI 0 JRNL AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, JRNL AUTH 2 G.M.CLORE JRNL TITL THE HIGH-RESOLUTION, THREE-DIMENSIONAL SOLUTION STRUCTURE OF JRNL TITL 2 HUMAN INTERLEUKIN-4 DETERMINED BY MULTIDIMENSIONAL JRNL TITL 3 HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY. JRNL REF BIOCHEMISTRY V. 32 6744 1993 JRNL REFN ISSN 0006-2960 JRNL PMID 8329398 JRNL DOI 10.1021/BI00077A030 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, REMARK 1 AUTH 2 G.M.CLORE REMARK 1 TITL THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 REMARK 1 TITL 2 BY MULTIDIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE REMARK 1 TITL 3 SPECTROSCOPY REMARK 1 REF SCIENCE V. 256 1673 1992 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, REMARK 1 AUTH 2 G.M.CLORE REMARK 1 TITL 1H, 15N, 13C AND 13CO ASSIGNMENTS OF HUMAN INTERLEUKIN-4 REMARK 1 TITL 2 USING THREE DIMENSIONAL DOUBLE-AND TRIPLE-RESONANCE REMARK 1 TITL 3 HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY REMARK 1 REF BIOCHEMISTRY V. 31 4334 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.S.GARRETT,R.POWERS,D.J.MARCH.E.A.FRIEDEN,G.M.CLORE, REMARK 1 AUTH 2 A.M.GRONENBORN REMARK 1 TITL DETERMINATION OF THE SECONDARY STRUCTURE AND FOLDING REMARK 1 TITL 2 TOPOLOGY OF HUMAN INTERLEUKIN-4 USING THREE-DIMENSIONAL REMARK 1 TITL 3 HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY REMARK 1 REF BIOCHEMISTRY V. 31 4347 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 DETAILS OF THE STRUCTURE DETERMINATION AND ALL STRUCTURAL REMARK 3 STATISTICS ARE GIVEN IN THE REFERENCE LISTED ON THE JRNL REMARK 3 RECORDS ABOVE (I.E. AGREEMENT WITH EXPERIMENTAL RESTRAINTS, REMARK 3 DEVIATIONS FROM IDEALITY FOR BOND LENGTHS, ANGLES, PLANES REMARK 3 AND CHIRALITY, NON-BONDED CONTACTS, ATOMIC RMS DIFFERENCES REMARK 3 BETWEEN THE CALCULATED STRUCTURES). REMARK 3 REMARK 3 THE STRUCTURES ARE BASED ON A TOTAL OF 2973 EXPERIMENTAL REMARK 3 NMR RESTRAINTS COMPRISING: 2515 INTERPROTON DISTANCE REMARK 3 RESTRAINTS DERIVED FROM NOE MEASUREMENTS; 102 REMARK 3 HYDROGEN-BONDING DISTANCE RESTRAINTS FOR 51 HYDROGEN-BONDS REMARK 3 IDENTIFIED ON THE BASIS OF THE NOE AND AMIDE PROTON REMARK 3 EXCHANGE DATA, AS WELL AS THE INITIAL STRUCTURE REMARK 3 CALCULATIONS; AND 130 PHI, 119 PSI, 73 CHI1, 32 CHI2 AND REMARK 3 2 CHI3 TORSION ANGLE RESTRAINTS DERIVED FROM COUPLING REMARK 3 CONSTANTS, NOE DATA, AND 13C SECONDARY CHEMICAL SHIFTS. REMARK 3 REMARK 3 THE METHOD USED TO DETERMINE THE STRUCTURES IS THE HYBRID REMARK 3 METRIC MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED REMARK 3 ANNEALING METHOD [NILGES, M., CLORE, G.M. & GRONENBORN, REMARK 3 A.M., FEBS LETT. 229, 317-324 (1988)]. REMARK 3 REMARK 3 A TOTAL OF 30 STRUCTURES WERE CALCULATED. THE ATOMIC RMS REMARK 3 DISTRIBUTION ABOUT THE MEAN COORDINATE POSITIONS FOR REMARK 3 RESIDUES 8 - 129 IS 0.44 (+/-0.03) ANGSTROMS FOR THE REMARK 3 BACKBONE ATOMS, 0.83 (+/-0.03) ANGSTROMS FOR ALL ATOMS, REMARK 3 AND 0.51 (+/-0.04) ANGSTROMS FOR ALL ATOMS EXCLUDING REMARK 3 DISORDERED SIDE CHAINS. THE N- (RESIDUES 1 - 7) AND C- REMARK 3 (RESIDUES 130 - 133) TERMINAL RESIDUES ARE DISORDERED. REMARK 3 REMARK 3 THE COORDINATES OF THE RESTRAINED MINIMIZED STRUCTURE ARE REMARK 3 LISTED FIRST AS MODEL 0. THIS (SA)R RESTRAINED MINIMIZED REMARK 3 MEAN STRUCTURE WAS DERIVED BY AVERAGING THE COORDINATES OF REMARK 3 THE INDIVIDUAL SA STRUCTURES (BEST FITTED TO RESIDUES 8 - REMARK 3 129) AND SUBJECTING THE RESULTING COORDINATES TO RESTRAINED REMARK 3 MINIMIZATION. THE QUANTITY PRESENTED IN THE TEMPERATURE REMARK 3 FACTOR FIELD (COLUMNS 61 - 66) REPRESENTS THE ATOMIC RMS REMARK 3 DEVIATIONS OF THE 30 INDIVIDUAL SA STRUCTURES ABOUT THE REMARK 3 MEAN STRUCTURE. RESIDUES 1 - 7 AND 130 - 133 AT THE N- REMARK 3 AND C-TERMINI, RESPECTIVELY, ARE DISORDERED. REMARK 4 REMARK 4 1ITI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174261. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 31 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -105.33 -51.80 REMARK 500 1 ALA A 4 -23.58 -169.16 REMARK 500 1 LYS A 6 25.26 -67.08 REMARK 500 1 ALA A 39 43.39 -157.69 REMARK 500 1 LYS A 41 -81.90 -130.05 REMARK 500 1 LYS A 46 -70.26 -52.72 REMARK 500 1 PHE A 59 -70.94 -83.19 REMARK 500 1 ARG A 68 -61.24 -100.25 REMARK 500 1 ALA A 72 -30.58 -138.47 REMARK 500 1 ARG A 89 -71.92 -83.71 REMARK 500 1 TRP A 95 -8.61 -56.86 REMARK 500 1 CYS A 103 65.71 -160.33 REMARK 500 1 LYS A 106 -130.13 -103.52 REMARK 500 1 ASP A 109 -105.43 -83.63 REMARK 500 1 GLU A 114 -74.83 -68.45 REMARK 500 1 TYR A 128 7.34 -65.42 REMARK 500 1 LYS A 130 -124.34 -156.61 REMARK 500 1 SER A 132 74.13 -105.38 REMARK 500 2 ALA A 4 -147.99 -159.04 REMARK 500 2 ALA A 38 27.89 -77.30 REMARK 500 2 ALA A 39 10.52 -147.75 REMARK 500 2 SER A 40 105.52 -55.62 REMARK 500 2 LYS A 41 -89.72 -145.18 REMARK 500 2 GLU A 64 -16.95 -47.27 REMARK 500 2 THR A 67 43.17 -93.13 REMARK 500 2 ARG A 68 -62.18 -95.76 REMARK 500 2 ALA A 72 -35.25 -147.37 REMARK 500 2 THR A 73 164.19 -48.11 REMARK 500 2 ARG A 89 -77.63 -90.09 REMARK 500 2 LEU A 94 -71.01 -58.35 REMARK 500 2 TRP A 95 -14.19 -48.54 REMARK 500 2 LEU A 97 -1.43 -59.83 REMARK 500 2 ALA A 98 -73.85 -81.88 REMARK 500 2 ASN A 101 -88.62 -87.66 REMARK 500 2 CYS A 103 68.20 -159.34 REMARK 500 2 LYS A 106 -106.85 -92.70 REMARK 500 2 ALA A 108 172.99 179.37 REMARK 500 2 ASP A 109 -120.54 -92.59 REMARK 500 2 LYS A 130 -115.44 -175.28 REMARK 500 2 SER A 132 56.59 -147.56 REMARK 500 3 GLN A 12 -71.00 -78.94 REMARK 500 3 ALA A 39 89.93 -165.01 REMARK 500 3 LYS A 41 -70.63 -145.70 REMARK 500 3 PHE A 59 -70.24 -83.56 REMARK 500 3 GLU A 64 -18.94 -47.58 REMARK 500 3 THR A 67 37.83 -95.69 REMARK 500 3 ARG A 68 -70.42 -93.77 REMARK 500 3 LEU A 70 -66.00 -94.52 REMARK 500 3 ARG A 89 -70.08 -76.07 REMARK 500 3 LEU A 97 -2.23 -59.06 REMARK 500 REMARK 500 THIS ENTRY HAS 655 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE NUMBERING SCHEME IN THIS STRUCTURE INCLUDES THE REMARK 999 FOUR-RESIDUE SEQUENCE GLU-ALA-GLU-ALA AT THE N-TERMINUS OF REMARK 999 THE RECOMBINANT PROTEIN WHICH IS NOT PART OF THE NATURAL REMARK 999 HUMAN IL-4; THE NATURAL IL-4 SEQUENCE THEREFORE STARTS AT REMARK 999 RESIDUE 5. REMARK 999 THE TWO POTENTIAL N-LINKED GLYCOSYLATION SITES AT ASN 42 REMARK 999 AND ASN 109 IN THE NATURAL SEQUENCE WERE CHANGED TO ASP TO REMARK 999 PREVENT HYPERGLYCOSYLATION IN THE YEAST HOST. DBREF 1ITI A 5 133 UNP P05112 IL4_HUMAN 25 153 SEQADV 1ITI ASP A 42 UNP P05112 ASN 62 CONFLICT SEQADV 1ITI ASP A 109 UNP P05112 ASN 129 CONFLICT SEQRES 1 A 133 GLU ALA GLU ALA HIS LYS CYS ASP ILE THR LEU GLN GLU SEQRES 2 A 133 ILE ILE LYS THR LEU ASN SER LEU THR GLU GLN LYS THR SEQRES 3 A 133 LEU CYS THR GLU LEU THR VAL THR ASP ILE PHE ALA ALA SEQRES 4 A 133 SER LYS ASP THR THR GLU LYS GLU THR PHE CYS ARG ALA SEQRES 5 A 133 ALA THR VAL LEU ARG GLN PHE TYR SER HIS HIS GLU LYS SEQRES 6 A 133 ASP THR ARG CYS LEU GLY ALA THR ALA GLN GLN PHE HIS SEQRES 7 A 133 ARG HIS LYS GLN LEU ILE ARG PHE LEU LYS ARG LEU ASP SEQRES 8 A 133 ARG ASN LEU TRP GLY LEU ALA GLY LEU ASN SER CYS PRO SEQRES 9 A 133 VAL LYS GLU ALA ASP GLN SER THR LEU GLU ASN PHE LEU SEQRES 10 A 133 GLU ARG LEU LYS THR ILE MET ARG GLU LYS TYR SER LYS SEQRES 11 A 133 CYS SER SER HELIX 1 1 ASP A 8 GLN A 24 1 17 HELIX 2 2 THR A 26 GLU A 30 5 5 HELIX 3 3 ILE A 36 SER A 40 5 5 HELIX 4 4 THR A 44 HIS A 63 1 20 HELIX 5 5 THR A 73 GLY A 99 1 27 HELIX 6 6 LEU A 113 TYR A 128 1 16 SHEET 1 A 2 THR A 32 VAL A 33 0 SHEET 2 A 2 SER A 111 THR A 112 -1 O SER A 111 N VAL A 33 SSBOND 1 CYS A 7 CYS A 131 1555 1555 2.02 SSBOND 2 CYS A 28 CYS A 69 1555 1555 2.02 SSBOND 3 CYS A 50 CYS A 103 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000